Mabwell (Shanghai) Bioscience (2493 HK)

Mabwell (Shanghai) Bioscience is a biopharmaceutical company focused on the research, development, production, and sales of therapeutic biological products, including macromolecular drugs, therapeutic monoclonal antibodies, and long-acting recombinant proteins. The company's pipeline addresses therapeutic areas such as oncology, autoimmunity, anti-infectives, and ophthalmology. It was founded in 2017 and is headquartered in Shanghai, China.